Fund Details
UTI Long Term Advantage Fund Series VII Regular Growth
| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.30% |
| NAV | ₹10.79 (14 Jan 2021) |
|---|---|
| Fund Started | 27 Mar 2018 |
| Fund Size | ₹277 Cr |
Returns
Comparison
Found nothing so far.
Found nothing so far.
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Mahindra & Mahindra Ltd. | Automobile | Equity | 6.1% |
| Escorts Ltd. | Automobile | Equity | 6.0% |
| ITC Ltd. | FMCG | Equity | 5.9% |
| Bharti Airtel Ltd. | Communication | Equity | 5.9% |
| Colgate-Palmolive (India) Ltd. | FMCG | Equity | 5.2% |
| PI Industries Ltd. | Chemicals | Equity | 5.1% |
| Chambal Fertilisers & Chemicals Ltd. | Chemicals | Equity | 5.0% |
| Mahindra & Mahindra Financial Services Ltd. | Financial | Equity | 5.0% |
| Coromandel International Ltd. | Chemicals | Equity | 4.7% |
| Rallis India Ltd. | Chemicals | Equity | 4.0% |
Fund Managers
UTI Long Term Advantage Fund Series VII Regular Growth Details
UTI Long Term Advantage Fund Series VII Regular Growth is a Equity Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 27 Mar 2018. Lalit Nambiar is the Current Fund Manager of UTI Long Term Advantage Fund Series VII Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹277 Cr and the Latest NAV as of 14 Jan 2021 is ₹10.79.
The UTI Long Term Advantage Fund Series VII Regular Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
Investment Objective
The investment objective of the scheme is to provide medium to long term capital appreciation along with income tax benefit.
Tax Implications
Upto Rs. 1.5 lac will be tax free under 80C. Lockin of 3 years. Returns will be taxed at 10%.
